Cambrex Corp. (CBM) – Press Releases
-
BioFlyte Forms Scientific Advisory Board of Prominent Government and Life Science Experts
-
Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility
-
Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit
-
Cambrex Announces Management Changes and Board Appointments
-
Cambrex Announces Completion of Acquisition by the Permira Funds
-
Old Dominion Freight Line Set to Join S&P 500; Cabot Microelectronics to Join S&P MidCap 400; Ready Capital and Industrial Logistics Properties Trust to Join S&P SmallCap 600
-
Cambrex Wins Third API Development Award at CPhI Worldwide
-
Cambrex Releases Selected Preliminary Third Quarter 2019 Financial Results
-
Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Highlands, Cambrex, Two River, and Carbon Black on behalf of Stockholders and Encourages Investors to Contact
-
Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement
-
Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Cambrex, Presidio, Old Line Bancorp, and Milacron Holdings on behalf of Stockholders and Encourages Investors
-
Cambrex Cancels Second Quarter Earnings Conference Call and Will Not Update Financial Guidance
-
Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash
-
Cambrex to Announce Second Quarter 2019 Financial Results on August 9, 2019
-
Cambrex to Double Size of Edinburgh Solid Form Screening Facility
-
Cambrex Strengthens Leadership Team to Support Integrated Small Molecule End-to-End Service Offering
-
Cambrex Appoints Dottie Donnelly-Brienza as Senior Vice President and Chief Human Resources Officer
-
Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site
-
Cambrex to Present at Upcoming Investor Conferences in June
-
Cambrex Reports First Quarter 2019 Financial Results
-
Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019
-
Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan
-
Cambrex Completes Highly Potent API Manufacturing Facility at Charles City, IA
-
Cambrex Doubles cGMP Liquid Filling Capacity at its Mirabel, Québec Facility
-
Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan
-
Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results
-
Cambrex to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019
-
Cambrex Completes Acquisition of Avista Pharma Solutions
-
Cambrex Expands Analytical Capabilities at its High Point, NC Site
-
Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network
-
Cambrex Reports Third Quarter 2018 Financial Results
-
Cambrex to Announce Third Quarter 2018 Financial Results on November 8, 2018
-
Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site
-
Cambrex to Expand and Invest at High Point, NC Site to Create New Center of Excellence for Process Development and Clinical Supply
-
Cambrex Completes Acquisition of Halo Pharma
-
Cambrex to Present at Upcoming Investor Conferences in September
-
Cambrex Reports Second Quarter 2018 Financial Results
-
Cambrex to Announce Second Quarter 2018 Financial Results on August 2, 2018
-
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network
-
Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site
-
Cambrex to Present at the Jefferies 2018 Global Healthcare Conference
-
Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga, Sweden Facility
-
Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility
-
Cambrex Reports First Quarter 2018 Financial Results
-
Cambrex to Announce First Quarter 2018 Financial Results on May 3, 2018
-
Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility
-
Cambrex Corporation to Provide Additional Information Regarding its Environmental, Social and Governance Practices
-
Cambrex Invests in New Continuous Flow Technology at its High Point, NC Facility
-
Cambrex to Present at the 2018 RBC Capital Markets Global Healthcare Conference
-
Cambrex Reports Fourth Quarter and Full Year 2017 Financial Results
Back to CBM Stock Lookup